Fumagalli Stefano, Pende Mario
Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, Paris, France.
Front Cell Dev Biol. 2022 Aug 12;10:949196. doi: 10.3389/fcell.2022.949196. eCollection 2022.
Genetic evidence in living organisms from yeast to plants and animals, including humans, unquestionably identifies the Target Of Rapamycin kinase (TOR or mTOR for mammalian/mechanistic) signal transduction pathway as a master regulator of growth through the control of cell size and cell number. Among the mTOR targets, the activation of p70 S6 kinase 1 (S6K1) is exquisitely sensitive to nutrient availability and rapamycin inhibition. Of note, analysis of mutant flies and mice reveals that S6K1 predominantly regulates cell size versus cell proliferation. Here we review the putative mechanisms of S6K1 action on cell size by considering the main functional categories of S6K1 targets: substrates involved in nucleic acid and protein synthesis, fat mass accumulation, retrograde control of insulin action, senescence program and cytoskeleton organization. We discuss how S6K1 may be involved in the observed interconnection between cell size, regenerative and ageing responses.
从酵母到植物、动物(包括人类)的生物体中的遗传学证据明确表明,雷帕霉素靶蛋白激酶(TOR,在哺乳动物中为mTOR/机制性TOR)信号转导途径是通过控制细胞大小和细胞数量来调节生长的主要调控因子。在mTOR的靶标中,p70 S6激酶1(S6K1)的激活对营养物质的可利用性和雷帕霉素抑制极为敏感。值得注意的是,对突变果蝇和小鼠的分析表明,S6K1主要调节细胞大小而非细胞增殖。在此,我们通过考虑S6K1靶标的主要功能类别来综述S6K1作用于细胞大小的假定机制:参与核酸和蛋白质合成、脂肪量积累、胰岛素作用的逆向调控、衰老程序和细胞骨架组织的底物。我们讨论了S6K1如何可能参与观察到的细胞大小、再生和衰老反应之间的相互联系。